-
Kentucky's Promising Opioid Addiction Treatment Initiative Stalls As New AG Ousts Leading Advocate
Friday, December 29, 2023 - 11:13am | 789Once a promising pioneer state in ibogaine research for the treatment of opioid use disorder, Kentucky’s appointment of Attorney General Russell Coleman has brought about the removal of Bryan Hubbard. As chair and executive director of the Kentucky Opioid Abatement Advisory Commission (KYOAAC...
-
Atai's Q2 2023 Plus Clinical Data On Ibogaine-Opioid Study, Pipeline's Psilocybin, DMT, Ketamine & MDMA
Thursday, August 10, 2023 - 5:06pm | 725Atai Life Sciences (NASDAQ: ATAI) reported its consolidated, unaudited financial results for the second quarter 2023 ended June 30. Numbers show: Cash, cash equivalents and short-term investments for $227.5 million, a 6-month $46.5 million operating activities disbursement considering the $273.1...
-
Novel Psychedelic Compound Shows Positive Results For Opioid Use Disorder Treatment
Wednesday, October 12, 2022 - 2:15pm | 463Kratom grows in several Asian countries and has been traditionally used by local communities as a natural home remedy for pain, depression and addiction. Now, several psychedelics companies are developing substances based on this plant and several US states have already enacted legislation that...
-
New Treatments For Opioid Addiction: Vaccine And CBD Product In Development
Tuesday, January 18, 2022 - 4:28pm | 658With drug overdoses having skyrocketed over the past two decades and deaths increased over four times in the period between 1999 and 2017, according to CDC data, it's no surprise that the number of those prone to opioid use disorder and opiate addiction is rising...